Q2
ZBH — Q2 2026 Financial Report Analysis
Zimmer Biomet's Q2 2026 sales rose 4.8% (4.0% organic) and GAAP EPS jumped 34% to $1.03 as Paragon 28 deal costs fell away, but adjusted operating profit slipped 3.3% and adjusted EPS stayed flat at $2.07; full-year guidance was raised.